Recruiting Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma NCT06207799 Conditions Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more Locations MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
